Unibio
Denmark
- Roskilde
- 03/04/2023
- Unknown
- $70,000,000
Join Unibio’s journey in solving the World’s protein scarcity challenge here.
One of the great challenges of humankind is how we can feed a fast-growing global population entitled to safe, healthy and affordable nutrition. In this endeavor, a robust supply of protein is key, a nutritional cornerstone and a necessary building block of all life and essential to the growth of cells and tissue repair. We believe the solution lies in Unibio’s high potential and mass-produced microbial protein; a tested, safe, eco-friendly, ethical technology approved by the EU capable of industrialising protein production for animal feed.
Unibio is committed to a journey towards a world without protein scarcity.
- Industry Biotechnology Research
- Website https://www.unibio.dk/investment/contact-us-for-investment-information/
- LinkedIn https://www.linkedin.com/company/unibio-a-s/
Related People
David HenstromFounder
Denmark -
Copenhagen, Capital Region
Experienced executive with a demonstrated history of working in the specialty food ingredient, health, nutrition, and water industries. Strong business development professional skilled in Business Planning, International Business, Team Building, Management, and Mergers & Acquisitions (M&A).
Iridius | $8,600,000 | (Apr 28, 2026)
Audion | $15,000,000 | (Apr 28, 2026)
Decade Energy | $25,763,540 | (Apr 28, 2026)
TriFetch | $1,900,000 | (Apr 28, 2026)
Fathom Therapeutics | $47,000,000 | (Apr 28, 2026)
SquareMind | $18,000,000 | (Apr 28, 2026)
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)
Cnuic Technologies | $3,000,000 | (Apr 28, 2026)
Zócalo Health | $15,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)